All News

A new cohort study links estrogen-only MHT use to reduced Alzheimer disease pathology.

Liz Miracle, PT, MPT, WCS, argues that ACOG Committee Opinion No. 736, which supports non-office postpartum assessment, applies equally to virtual pelvic floor physical therapy.

Included are statements from SMFM, ACOG, and the AAP.

A new LifeStance survey finds many women are unaware that perimenopause can affect mental health.

One in 3 counties in the United States remain maternity care deserts as 96 L&D closures compound access gaps, per March of Dimes.

Women with type 2 diabetes reported more and worse menopause symptoms, especially in the postmenopause stage.

Liz Miracle, PT, MPT, WCS, discusses clinician-identified advantages of virtual pelvic health care, including access, psychological safety, and in-home assessment.

AbCellera's ABCL635 met primary efficacy endpoints in a Phase 2 trial for moderate-to-severe hot flashes.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Damian Alagia, III, MD, attributes gaps in prenatal STI detection and treatment to systemic flaws in access rather than individual clinical judgment.

This review aims to go beyond the basics by exploring advanced interpretations for clinical referral to support ob-gyn providers in translating urinalysis findings into practical care decisions.

A University of Michigan pilot study, discussed here by lead researcher Alex F. Peahl, MD, MSc, found patient-operated remote ultrasonography feasible for completing biophysical profiles in high-risk pregnancies.

The FDA has cleared the Revi Extend, furthering the system's lifespan to 15 years to treat UUI.

Michael A. Reed, MD, MSCP, outlines immediate, practical steps physicians can take to address women's sexual health in their current roles.

Jeffrey Jensen, MD, MPH, explains the Gwyn Lo patch's Pearl Index following its recent FDA approval.

Michael A. Reed, MD, MSCP, explains how a structured framework for women's sexual health can address fragmentation and legitimize concerns often dismissed in routine care.

One in 3 FQHCs lack on-site prenatal care, with gaps concentrated in maternity deserts, a national study finds.

Jeffrey Jensen, MD, MPH, welcomes the newly approved Gwyn Lo contraceptive patch as an expanded, low-estrogen option for patients seeking a once-weekly method.

A curated look at the most engaging expert interviews from Contemporary OB/GYN in July 2026, highlighting clinician perspectives on endometriosis, perinatal mental health, menopause, and emerging therapeutic insights.

As we close out July, take a look back at key women's health FDA and other regulatory updates from the month.

Joy Baker, MD, FACOG, explains how zuranolone's rapid onset gives clinicians a meaningfully different counseling conversation for PPD.

BV-positive women had higher STI coinfection rates than BV-negative women in a study from Quest Diagnostics and Hologic, Inc.

Spring Fertility launched the Personalized IVF Calculator built on 2M+ data points from 25,000+ cycles.

FDA approved norelgestromin and ethinyl estradiol (Gwyn Lo; Viatris) as a low-dose once-weekly contraceptive patch.

Michael A. Reed, MD, MSCP, proposes a “Fourth Pillar” framework to integrate women's sexual health alongside reproduction, disease treatment, and longevity in clinical practice.

A cohort study of 15,382 mother-infant dyads found that subfecundity was independently associated with elevated autism spectrum disorder odds and behavioral problem scores in offspring, while IVF treatment showed no significant neurodevelopmental associations.

Corresponding author Cynthia Gyamfi-Bannerman, MD, MS, says late preterm hypoglycemia did not adversely affect neurodevelopment.

Natural Cycles received a sixth FDA clearance for an updated version of its fertility-tracking algorithm.